QIAO Wei-lin,ZHANG Li-hang,PENG Li-hua,et al.Study on the Material Basis and Quality Standard Improvement of Zhuangyao Jianshen Tablets[J].Journal of Instrumental Analysis,2023,42(04):402-410.
QIAO Wei-lin,ZHANG Li-hang,PENG Li-hua,et al.Study on the Material Basis and Quality Standard Improvement of Zhuangyao Jianshen Tablets[J].Journal of Instrumental Analysis,2023,42(04):402-410. DOI: 10.19969/j.fxcsxb.22120603.
Study on the Material Basis and Quality Standard Improvement of Zhuangyao Jianshen Tablets
An ultrahigh performance liquid chromatography-quadrupole time-of-flight mass spectrometry(UPLC-Q-TOF MS,E,) with UNIFI software analysis was used to analyze the chemical components in Zhuangyao Jianshen tablets.The active components were screened by ADMETlab and TCMSP database,of which 55 potential active components were found.The galic acid,protocatechuic acid and protocatechuic aldehyde were determined as the content determination index,based on the comprehensive evaluation of active components and the pharmacological activity literature related to the function of Zhuangyao Jianshen tablets.Meanwhile,a high performance liquid chromatography(HPLC) method was established to detect the contents of galic acid,protocatechuic acid,protocatechuic aldehyde in 15 batches of samples,which were 0.135 3-0.344 8 mg/g,0.430 8-0.946 3 mg/g and 0.042 4-0.107 7 mg/g,respectively.The HPLC fingerprints for 15 batches of Zhuangyao Jianshen tablets were established,15 common peaks were calibrated and attributed to the Chinese medicine of the prescription with their similarities between 0.988 and 1.000,which showed that the inter-batch consistency of ingredients were high.Compared with those in the original standard,the newly established analytical indexes in this paper could more comprehensively characterize and evaluate the quality of Zhuangyao Jianshen tablets,and provide a scientific basis for the effective material analysis and the improvement of the quality standard.It is of great significance to improve the quality controllability of the product.
Chinese Pharmacopoeia Commission. Drug Standards of the Ministry of Health of the People’s Republic of China.Tradi-tional Chinese Medicine Prescription Preparation(13 th). Beijing:People’s Medical Publishing House(国家药典委员会.中华人民共和国卫生部药品标准·中药成方制剂.第十三册.北京:人民卫生出版社),1997:73.
Hu J,Hu Z Z.J. Youjiang Med. Univ. Natl. (胡建,胡忠泽.右江民族医学院学报),2021,43(4):460-464.
Luo H W.Chin. Mod. Med. (罗华文.中国当代医药),2018,25(6):94-95.
Tao X H,Xue L X,Liu C.China’s Naturopathy(陶向辉,薛丽霞,刘纯.中国民间疗法),2020,28(14):54-56.
Zhao W M.Lishizhen Med. Mater. Med. Res. (赵为民.时珍国医国药),2011,22(11):2811-2812.
Han W N,Han G,Xu Q Z,Xu Y.World J. Integrated Tradit. Western Med. (韩万年,韩光,徐全中,徐阳.世界中西医结合杂志),2007,2(suppl):113-114.
Cai B,Cheng B D,Qiang J H.Drugs Clin. (蔡波,成百朵,强建红.现代药物与临床),2016,31(9):1399-1402.
Chen J Y,Jiang W W,He F L,Mo G Q,Guo Z H,Wang X D,Wu Q H,Cao H Y.China J. Chin. Mater. Med. 陈家艺,江伟雯,何风雷,莫国强,郭钟慧,王笑丹,吴清和,操红缨.中国中药杂志),2015,40(15):3059-3062.
Lian Q W,He F L,Mo G Q,Guo Z H,Wang X D,Fan P L,Wu Q H,Cao H Y,Huang P.J. Guangdong Pharm. Univ. (练庆旺,何风雷,莫国强,郭钟慧,王笑丹,范平龙,吴清和,操红缨,黄萍.广东药学院学报),2015,31(2):215-218.
Li G J,Xu Z D,Liu Y F,Li C H.J. Chin. Med. Mater. (李国驹,许招懂,刘袁芳,李灿辉.中药材),2006,29(4):365-367.
He C D,Chen Z Q,Xu Z X,Dai B Y.Strait Pharm. J. (何承队,陈振铨,许则省,戴碧怡.海峡药学),2022,34(2):75-78.
Wang X Q,Lü W S,Lin T.Tradit. Chin. Drug Res. Clin. Pharm. (王秀芹,吕渭升,林彤.中药新药与临床药理),2016,27(6):855-859.
Hu W J,Fu J,Tang X Y,Wang Y.J. Guangdong Pharm. Univ. (胡伟杰,符健,汤小燕,王岩.广东药学院学报),2016,32(3):330-334.
Niu X L,Zhang T P,Shi H,Zhang W.J. Hebei Tradit. Chin. Med. Pharm. (牛秀丽,张天鹏,石红,张旺.河北中医药学报),2015,30(2):58-60.
Chen L.Jiangxi J. Tradit. Chin. Med. (陈乐.江西中医药),2013,44(361):59-60.
Chen X M,Zhao C.Asia-Pac. Tradit. Med. (陈霞明,赵成.亚太传统医药),2013,9(6):44-45.
Adefegha S A,Oboh G,Ejakpovi I I,Oyeleye S I.Com. Clin. Pathol.,2015,24(6):1579-1585.
Ajiboye T O,Habibu R S,Saidu K.MicrobiologyOpen,2017,6(4):e472.
Tsao S M,Hsia T C,Yin M C.Nutr. Cancer,2014,66(8):1331-1341.
Winter A N,Brenner M C,Punessen N.Oxid. Med. Cell. Longevity,2017:6297080.